GlassScriptPhysician profile
Jay Bradley Bitar
NPI 1396795928
$4,023.70
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $639 · 2021: $190 · 2022: $335 · 2023: $2,844 · 2024: $16.23.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,980 · Food and Beverage: $880.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,979.70 |
| Food and Beverage | $880.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $2,354.51 | 2020-2023 | Impella |
| Penumbra, INC. | $613.08 | 2020 | |
| Inari Medical, INC. | $293.55 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Abbott Laboratories | $157.89 | 2022 | |
| Shockwave Medical, INC | $123.97 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Amgen INC. | $119.98 | 2023 | Repatha |
| Boehringer Ingelheim Pharmaceuticals, INC. | $109.49 | 2023 | Jardiance |
| Philips North America LLC | $68.52 | 2023 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $55.38 | 2023 | Lifevest |
| Novartis Pharmaceuticals Corporation | $52.56 | 2023 | |
| Boston Scientific Corporation | $38.41 | 2023-2024 | Latitude Communicator Power Supply, Acuity Steerable |
| Elutia, INC. | $36.36 | 2022-2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jay Bitar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.